Duality Biotherapeutics Chairman’s Shareholding Increase Expected to Reach Up to $10 Million
Duality Biotherapeutics said its chairman’s total shareholding increase is expected to be up to $10 million.
Related stories
Nasdaq halts trading for volatility at 09:30 a.m.
M impact | EQUITY | Oct 29, 2026, 01:39 PM UTC
Alphabet Shares Hit Near Seven-Month Low After Revenue Miss, Worsening Cash Burn
Alphabet shares hit a near seven-month low after a quarterly revenue miss and worsening cash burn.
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
S&P 500 Falls 39.78 Points to 7,704.20
The S&P 500 was down 39.78 points at 7,704.20 after the market open.
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Nasdaq volatility trading pause at 09:30 AM
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Nasdaq falls 362.53 points to 26,187.32 after open
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC
Dow Jones falls 272.87 points to 52,202.23 after open
M impact | EQUITY | Oct 29, 2026, 01:33 PM UTC